Sherbrooke Park Advisers’s MiMedx Group MDXG Stock Holding History

Sherbrooke Park Advisers’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$112K	Buy	+16,500	New	+$116K	0.29%	123
2025 Q3	–	Sell	-14,463	Closed	-$88.4K	–	642
2025 Q2	$88.4K	Buy	+14,463	New	+$96.2K	0.04%	472
2025 Q1	–	Sell	-12,205	Closed	-$117K	–	806
2024 Q4	$117K	Sell	12,205 -86,374	-88%	-$673K	0.04%	651
2024 Q3	$583K	Buy	98,579 +21,002	+27%	+$139K	0.13%	245
2024 Q2	$538K	Buy	77,577 +22,460	+41%	+$158K	0.09%	376
2024 Q1	$424K	Buy	+55,117	New	+$443K	0.08%	426

Other funds holding MDXG

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Sherbrooke Park Advisers's MDXG Position: Q4 2025 in Review

Sherbrooke Park Advisers opened a new position in MiMedx Group (MDXG) in Q4 2025: 16,500 shares worth $112K. The stake represents 0.29% of the portfolio and ranks #123 among its holdings. This is a return to the name: Sherbrooke Park Advisers previously reported a position in MDXG as recently as Q2 2025.

Sherbrooke Park Advisers first reported a position in MDXG in Q1 2024 and has held it in 6 quarters since. The position peaked at $583K in Q3 2024. 233 funds tracked by Wall St. Rank hold MDXG as of Q4 2025.

Sherbrooke Park Advisers held 16,500 shares of MiMedx Group worth $112K as of Q4 2025.
MiMedx Group was a new Sherbrooke Park Advisers position in Q4 2025.
MiMedx Group made up 0.29% of Sherbrooke Park Advisers's portfolio in Q4 2025, its #123 holding.
Sherbrooke Park Advisers first reported a position in MiMedx Group in Q1 2024 and has held it in 6 quarters since.
Sherbrooke Park Advisers's MiMedx Group position peaked at $583K in Q3 2024.
233 funds tracked by Wall St. Rank held MiMedx Group as of Q4 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.